Eileen G. Gorman, PhD, USPTO Registered Patent Agent
With twenty-five years experience in the
medical products and life sciences industry, Dr. Eileen
Gorman has worked in all aspects of the industry, including
raising capital, strategic planning, managing
academic-industrial partnership and interfacing with
manufacturing. She has helped early stage biotechnology
companies raise over $10 million in non-diluting funds that
clients levered into further funding. She has developed
strategic, marketing and technical analysis for companies
ranging from clinical diagnostics, gene-based medicine,
analytical instrument equipment, disease focuses including
several cancers, infectious diseases among others. She has
translated this experience as chair of business sessions at
both BIO and the American Association of Clinical Chemistry
Conferences. She has been a guest speaker at local sections
of the AACC as well.
Her experience includes 15 years at DuPont Diagnostics (now
Siemens) where she rose from Research Scientist through the
ranks to Research management including Technical Marketing
Management. During this time she was responsible for
commercialization of 5 products that were fully integrated
into clinical systems. She had leadership responsibility for
groups interfacing with Manufacturing, Sales, Service and
Business Leadership and Management for day-to-day operation
of a $500 million dollar business.
Dr. Eileen Gorman has an outstanding record of achievement
in basic research and product development. Dr. Gorman is an
inventor on one issued patent and is the author of over 50
papers, chapters, abstracts, and corporate reports. She was
a Staff Fellow at the NHLBI at the National Institutes of
College of Science, University of Texas at El Paso, Golden Nugget Award, 2008.
Mentor of the Year Award, Science Center, Philadelphia, PA, 2003
Elizabeth Bingham award from AWIS PHL, Philadelphia chapter of the Association for Women in Science, 2000. Award for mentoring and fostering careers in science.
Gorman, EG, Diagnostic
(in vitro) Products - The New Futures of Diagnostic
Testing, Biomedical Medical and Healthcare Market Place
Guide, ed. Dorland’s Biomedical: 2002-2003, vol. 1;
Gorman, EG, Building a
diagnostics market: One molecule at a time. IVD Technology,
vol. 7 pg. 59-67.
Gorman, EG, The New
Futures of Diagnostic Testing, Clinical Leadership &
Management Review, vol. 14:1, p. 26-29, 2000.
Newman, DJ, Y. Olabiran, W.D.
Bedzyk, S. Chance, Gorman, EG and C.P. Price,
Impact of Antibody Specificity and Calibration Material on
the Measure of Agreement between Methods for Cardiac
Troponin I, Clinical Chemistry, p. 822-828, 1999.
Price, C.P., J. Calvin, S. A.
Walker, A. K. Trull, D. J. Newman, and Gorman, EG.
A Rapid and Sensitive Automated Light Scattering Immunoassay
for Serum C-reactive protein and the Definition of a
Reference Range in Healthy Blood Donors, Clin Chem Lab
Med, p. 107-113, 1999.
Diagnostic (in vitro) Products - The New Futures
of Diagnostic Testing, Biomedical Medical and Healthcare
Market Place Guide, vol. 1 , p.1545-1547, 1998.
Gorman, EG, S.P. Kramer, I.S. Masulli, E.A. Nuzzai,
and W.F. Skogen, Analytical and Clinical Performance of a
Rapid Screening Method for Cannabinoids on the Dimension®
Clinical Chemistry System, Journal of Automatic
Chemistry, 19/5, 169-173, 1997.
R. Arentzen, W. Bedzyk, and LA. Cassidy, An Overview of
Immunoassay Automation, 2nd Edition, in Principles and
Practice of Immunoassay, C.P. Price and D.J. Newman, Eds.
High Refractive Index
Haloalkyl-Functional Shell-Core Polymers and Their
Use in Light Scattering Immunoassays
"We are already
looking into using them again."
- President at a biotechnology company.